Atlas Trials

A Clinical Study to Determine Biomarkers of Response to a Gamma Secretase Inhibitor

Clinical trial NCT00803894 · COMPLETED

Trial details

NCT number
NCT00803894
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2008-12-01
Primary completion
2009-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.